Phosphorylated Extracellular Signal-regulated Kinase Up-regulated P53 Expression in Shikonin-induced HeLa Cell Apoptosis
Overview
Affiliations
Background: The role of extracellular signal-regulated kinase 1/2 (ERK1/2) in shikonin-induced HeLa cells apoptosis remains vague. This study was to investigate the activation of caspase pathways and the role of ERK1/2 in human cervical cancer cells, HeLa, by shikonin.
Methods: The inhibitory effect of shikonin on the growth of HeLa cells was measured by MTT assay. Fluorescent microscopic analysis of apoptotic cells stained with 4',6'-oliiamiclino-2-phenylindole C (DAPI) and Hoechst 33258 was carried out. Caspase-3 and -8 activities were detected using caspase-3 substrate and caspase-8 substrate as substrates, respectively. The protein levels of ERK, p53 and p-ERK were determined by Western blot analysis.
Results: Shikonin inhibited cell growth in a time- and dose-dependent manner. Caspase-3 and caspase-8 were activated in the apoptotic process and caspase inhibitors effectively reversed shikonin-induced apoptosis. Phosphorylation of ERK resulted in up-regulation of p53 expression, which was blocked by mitogen-activated protein kinase (MEK), inhibitor PD 98059.
Conclusion: Shikonin induces HeLa cell apoptosis through the ERK, p53 and caspase pathways.
PPARγ Agonists: Emergent Therapy in Endometriosis.
Vallee A, Vallee J, Le Blanche A, Lecarpentier Y Pharmaceuticals (Basel). 2021; 14(6).
PMID: 34204039 PMC: 8229142. DOI: 10.3390/ph14060543.
Identification and biochemical characterisation of Acanthamoeba castellanii cysteine protease 3.
Wang Z, Wu D, Tachibana H, Feng M, Cheng X Parasit Vectors. 2020; 13(1):592.
PMID: 33228764 PMC: 7685649. DOI: 10.1186/s13071-020-04474-8.
Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction.
Wang F, Pozo F, Tian D, Geng X, Yao X, Zhang Y Front Pharmacol. 2020; 11:861.
PMID: 32581812 PMC: 7296065. DOI: 10.3389/fphar.2020.00861.
Vallee A, Lecarpentier Y Int J Mol Sci. 2020; 21(7).
PMID: 32244563 PMC: 7177778. DOI: 10.3390/ijms21072440.
Tang Q, Liu L, Zhang H, Xiao J, Hann S Drug Des Devel Ther. 2020; 14:577-589.
PMID: 32103900 PMC: 7023881. DOI: 10.2147/DDDT.S236216.